Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime

References

• Agarwal R, Katare O, Vyas S. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
   PubMed Web of Science ®Google Scholar
• Akuodor G, Usman MI, Ibrahim J, Chilaka K, Akpan J, Dzarma S, et al. 2013. Anti-nociceptive, anti-inflammatory and antipyretic effects of the methanolic extract of Bombax buonopozense leaves in rats and mice. Afr J Biotechnol. 10:3191–3196.
   Google Scholar
• Arfan M, Amin H, Khan I, Shah MR, Shah H, Khan AZ, et al. 2012. Molecular simulations of bergenin as a new urease inhibitor. Med Chem Res. 21:2454–2457.
   Web of Science ®Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, Donia AM. 2007. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech. 8:206–212.
   Web of Science ®Google Scholar
• Bárány E, Lindberg M, Lodén M. 1999. Biophysical characterization of skin damage and recovery after exposure to different surfactants. Contact Dermatitis. 40:98–103.
   PubMed Web of Science ®Google Scholar
• Bragagni M, Mennini N, Furlanetto S, Orlandini S, Ghelardini C, Mura P. 2014. Development and characterization of functionalized niosomes for brain targeting of dynorphin-B. Eur J Pharm Biopharm. 87:73–79.
   PubMed Web of Science ®Google Scholar
• Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micieli D, et al. 2008. Biocompatibility of poly(d,l-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials. 29:1400–1411.
   PubMed Web of Science ®Google Scholar
• Chen D, Yu H, Mu H, Li G, Shen Y. 2014. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery. Artif Cells Nanomed Biotechnol. 42:205–209.
   PubMed Web of Science ®Google Scholar
• Egan P. 1989. Surfactants from biomass. Chemtech. 19:758–762.
   Google Scholar
• Essa E. 2010. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 4:227.
   Google Scholar
• Estanqueiro M, Amaral MH, Conceição J, Lobo JMS. 2015. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces. 126:631–648.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, Yang Y, Li K. 2002. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 244:73–80.
   PubMed Web of Science ®Google Scholar
• Holmberg K. 2003. Novel Surfactants: Preparation Applications and Biodegradability, Revised and Expanded. Florida, USA: CRC Press.
   Google Scholar
• Jain S, Valvi PU, Swarnakar NK, Thanki K. 2012. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol Pharm. 9:2542–2553.
   PubMed Web of Science ®Google Scholar
• Kong M, Park H, Feng C, Hou L, Cheng X, Chen X. 2013. Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy. Carbohydr Polym. 94:634–641.
   PubMed Web of Science ®Google Scholar
• Krewski D, Andersen ME, Mantus E, Zeise L. 2009. Reply to invited commentaries on toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29:492–497.
   Web of Science ®Google Scholar
• Li Y-F, Hu L-H, Lou F-C, Li J, Shen Q. 2005. PTP1B inhibitors from Ardisia japonica. J Asian Nat Prod Res. 7:13–18.
   PubMed Web of Science ®Google Scholar
• Lim H-K, Kim H-S, Chung M-W, Kim YC. 2000. Protective effects of bergenin, the major constituent of Mallotus japonicus, on d-galactosamine-intoxicated rat hepatocytes. J Ethnopharmacol. 70:69–72.
   PubMed Web of Science ®Google Scholar
• Mahale N, Thakkar P, Mali R, Walunj D, Chaudhari S. 2012. Niosomes: novel sustained release nonionic stable vesicular systems—an overview. Adv Colloid Interface Sci. 183:46–54.
   PubMed Web of Science ®Google Scholar
• Ménard N, Tsapis N, Poirier C, Arnauld T, Moine L, Lefoulon F, et al. 2012. Drug solubilization and in vitro toxicity evaluation of lipoamino acid surfactants. Int J Pharm. 423:312–320.
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere N, Inman A, Zhang L. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 234:222–235.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L, La Mesa C. 2013. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties. Int J Pharm. 458:224–229.
   PubMed Web of Science ®Google Scholar
• Nazir N, Koul S, Qurishi MA, Taneja SC, Ahmad SF, Bani S, Qazi GN. 2007. Immunomodulatory effect of bergenin and norbergenin against adjuvant-induced arthritis-a flow cytometric study. J Ethnopharmacol. 112:401–405.
   PubMed Web of Science ®Google Scholar
• Neimert-Andersson K, Sauer S, Panknin O, Borg T, Söderlind E, Somfai P. 2006. Synthesis of new sugar-based surfactants and evaluation of their hemolytic activities. J Org Chem. 71:3623–3626.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, Goyal AK. 2014. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. 42:406–412.
   PubMed Web of Science ®Google Scholar
• Pethica B, Schulman J. 1953. The physical chemistry of haemolysis by surface-active agents. Biochem J. 53:177.
   PubMed Web of Science ®Google Scholar
• Pignatello R, Paolino D, Panto V, Pistara V, Calvagno M, Russo D, et al. 2009. Lipoamino acid prodrugs of paclitaxel: synthesis and cytotoxicity evaluation on human anaplastic thyroid carcinoma cells. Curr Cancer Drug Targets. 9:202–213.
   PubMed Web of Science ®Google Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. 2011. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 34:945–953.
   PubMed Web of Science ®Google Scholar
• Schwendener R, Asanger M, Weder H. 1981. n-alkyl-glucosides as detergents for the preparation of highly homogeneous bilayer liposomes of variable sizes (60–240 nm phi) applying defined rates of detergent removal by dialysis. Biochem Biophys Res Commun. 100:1055–1062.
   PubMed Web of Science ®Google Scholar
• Šentjurc M, Vrhovnik K, Kristl J. 1999. Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release. 59:87–97.
   PubMed Web of Science ®Google Scholar
• Shah MR, Arfan M, Amin H, Hussain Z, Qadir MI, Choudhary MI, et al. 2012. Synthesis of new bergenin derivatives as potent inhibitors of inflammatory mediators NO and TNF-α. Bioorg Med Chem Lett. 22:2744–2747.
   PubMed Web of Science ®Google Scholar
• Shi B, Fang C, Pei Y. 2006. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci. 95:1873–1887.
   PubMed Web of Science ®Google Scholar
• Singh D, Pradhan M, Nag M, Singh MR. 2015. Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol. 43:282–290.
   PubMed Web of Science ®Google Scholar
• Söderlind E, Wollbratt M, von Corswant C. 2003. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int J Pharm. 252:61–71.
   PubMed Web of Science ®Google Scholar
• Strickley RG. 2004. Solubilizing excipients in oral and injectable formulations. Pharm Res. 21:201–230.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kosaka M, Watanabe Y, Nakade K, Fukuyama Y. 2003. Synthesis and neuroprotective activity of bergenin derivatives with antioxidant activity. Bioorg Med Chem. 11:1781–1788.
   PubMed Web of Science ®Google Scholar
• Tavano L, Gentile L, Rossi O, Muzzalupo R. 2013. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery. Colloids Surf B Biointerfaces. 110:281–288.
   PubMed Web of Science ®Google Scholar
• Ullah S, Shah MR, Shoaib M, Imran M, Elhissi AM, Ahmad F, et al. 2016. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. Drug Deliv. 1–12.
   PubMed Web of Science ®Google Scholar
• Valdés K, Morill MJ, Romero E, Chávez J. 2014. Physicochemical characterization and cytotoxic studies of nonionic surfactant vesicles using sucrose esters as oral delivery systems. Colloids Surf B Biointerfaces. 117:1–6.
   PubMed Web of Science ®Google Scholar
• Verma D, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 258:141–151.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 105:1–6.
   Web of Science ®Google Scholar